
Gary F. Paumen
Examiner (ID: 14250, Phone: (571)272-2013 , Office: P/2833 )
| Most Active Art Unit | 2834 |
| Art Unit(s) | 2832, 0, 2833, 2899, 3202, 2834 |
| Total Applications | 7178 |
| Issued Applications | 6211 |
| Pending Applications | 288 |
| Abandoned Applications | 743 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18953735
[patent_doc_number] => 20240042062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE
[patent_app_type] => utility
[patent_app_number] => 18/380388
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380388
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380388 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | Oct 15, 2023 | Pending |
Array
(
[id] => 18989015
[patent_doc_number] => 20240060984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => 1,1 '-[[(SUBSTITUTED ALKYL)IMINO]BIS(ALKYLENE)]BIS-FERROCENES AND THEIR USE IN ELECTROCHEMICAL ASSAYS BY LABELLING SUBSTRATES OF INTEREST
[patent_app_type] => utility
[patent_app_number] => 18/485575
[patent_app_country] => US
[patent_app_date] => 2023-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18485575
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/485575 | 1,1'-[(substituted alkyl)imino]bis(alkylene)]bis-ferrocenes and their use in electrochemical assays by labelling substrates of interest | Oct 11, 2023 | Issued |
Array
(
[id] => 18924452
[patent_doc_number] => 20240027456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => LUNG CANCER BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 18/376575
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18376575
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/376575 | LUNG CANCER BIOMARKERS | Oct 3, 2023 | Pending |
Array
(
[id] => 18896518
[patent_doc_number] => 20240012003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => MULTIPLEXED TOTAL ANTIBODY AND ANTIBODY-CONJUGATED DRUG QUANTIFICATION ASSAY
[patent_app_type] => utility
[patent_app_number] => 18/370295
[patent_app_country] => US
[patent_app_date] => 2023-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18370295
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/370295 | MULTIPLEXED TOTAL ANTIBODY AND ANTIBODY-CONJUGATED DRUG QUANTIFICATION ASSAY | Sep 18, 2023 | Pending |
Array
(
[id] => 18989000
[patent_doc_number] => 20240060969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => METHOD OF DETERMINING THE PRESENCE OR ABSENCE OF A
TARGET ANALYTE COMPRISING USING A REPORTER
POLYNUCLEOTIDE AND A TRANSMEMBRANE PORE
[patent_app_type] => utility
[patent_app_number] => 18/454975
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18454975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/454975 | METHOD OF DETERMINING THE PRESENCE OR ABSENCE OF A TARGET ANALYTE COMPRISING USING A REPORTER POLYNUCLEOTIDE AND A TRANSMEMBRANE PORE | Aug 23, 2023 | Pending |
Array
(
[id] => 18818749
[patent_doc_number] => 20230393089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => COMPOUNDS AND THEIR USE IN ANALYTICAL METHODS
[patent_app_type] => utility
[patent_app_number] => 18/449936
[patent_app_country] => US
[patent_app_date] => 2023-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18449936
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/449936 | COMPOUNDS AND THEIR USE IN ANALYTICAL METHODS | Aug 14, 2023 | Pending |
Array
(
[id] => 18956464
[patent_doc_number] => 20240044791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => NANOSTRUCTURES FOR IMPROVED MOLECULAR DETECTION
[patent_app_type] => utility
[patent_app_number] => 18/349016
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18349016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/349016 | NANOSTRUCTURES FOR IMPROVED MOLECULAR DETECTION | Jul 6, 2023 | Abandoned |
Array
(
[id] => 18903958
[patent_doc_number] => 20240019443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => METHODS FOR CHARACTERIZING PROTEIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 18/218957
[patent_app_country] => US
[patent_app_date] => 2023-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18218957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/218957 | Methods for characterizing protein complexes | Jul 5, 2023 | Issued |
Array
(
[id] => 18740932
[patent_doc_number] => 20230349911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS AND METHODS TO QUANTIFY THE BINDING INTERACTIONS OF MYOSIN BINDING-PROTEIN C (MYBP-C)
[patent_app_type] => utility
[patent_app_number] => 18/310301
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310301 | COMPOSITIONS AND METHODS TO QUANTIFY THE BINDING INTERACTIONS OF MYOSIN BINDING-PROTEIN C (MYBP-C) | Apr 30, 2023 | Pending |
Array
(
[id] => 19625133
[patent_doc_number] => 12163955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Antibodies to methotrexate and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/186899
[patent_app_country] => US
[patent_app_date] => 2023-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 33958
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18186899
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/186899 | Antibodies to methotrexate and uses thereof | Mar 19, 2023 | Issued |
Array
(
[id] => 19694244
[patent_doc_number] => 20250012789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => MAGNETIC CHEMILUMINESCENCE IMMUNOASSAY KIT BASED ON BIFUNCTIONAL FUSION PROTEIN FOR MYCOTOXINS, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/722997
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18722997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/722997 | Magnetic chemiluminescence immunoassay kit based on bifunctional fusion protein for mycotoxins, and use thereof | Feb 16, 2023 | Issued |
Array
(
[id] => 18453227
[patent_doc_number] => 20230194507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => QUANTITATION OF FUNCTIONAL GROUPS ON SOLID SUPPORTS
[patent_app_type] => utility
[patent_app_number] => 18/170481
[patent_app_country] => US
[patent_app_date] => 2023-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18170481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/170481 | Quantitation of functional groups on solid supports | Feb 15, 2023 | Issued |
Array
(
[id] => 18307188
[patent_doc_number] => 20230111088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => ANTI-DRUG ANTIBODY ASSAY
[patent_app_type] => utility
[patent_app_number] => 18/077673
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077673
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/077673 | ANTI-DRUG ANTIBODY ASSAY | Dec 7, 2022 | Abandoned |
Array
(
[id] => 18294349
[patent_doc_number] => 20230104035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHOD FOR DETERMINING ANTIBODY DISSOCIATION RATE
[patent_app_type] => utility
[patent_app_number] => 18/061893
[patent_app_country] => US
[patent_app_date] => 2022-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061893
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061893 | METHOD FOR DETERMINING ANTIBODY DISSOCIATION RATE | Dec 4, 2022 | Pending |
Array
(
[id] => 18421578
[patent_doc_number] => 20230176041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => DETECTION OF PAR IN THE CSF OF PATIENTS WITH PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/049773
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049773 | Detection of PAR in the CSF of patients with Parkinson's disease | Oct 25, 2022 | Issued |
Array
(
[id] => 18326387
[patent_doc_number] => 20230124515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => NANOZYME LINKED BIOASSAY AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/963376
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963376 | NANOZYME LINKED BIOASSAY AND ASSOCIATED METHODS | Oct 10, 2022 | Pending |
Array
(
[id] => 18374753
[patent_doc_number] => 20230149832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => SURFACE FUNCTIONALIZED AFFINITY MEMBRANES
[patent_app_type] => utility
[patent_app_number] => 17/937251
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937251 | SURFACE FUNCTIONALIZED AFFINITY MEMBRANES | Sep 29, 2022 | Pending |
Array
(
[id] => 19027332
[patent_doc_number] => 11926679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method
[patent_app_type] => utility
[patent_app_number] => 17/934200
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 10305
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934200 | Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method | Sep 21, 2022 | Issued |
Array
(
[id] => 18227533
[patent_doc_number] => 20230066527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => THERAPEUTIC PROTEIN SELECTION IN SIMULATED IN VIVO CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/892618
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892618 | Therapeutic protein selection in simulated in vivo conditions | Aug 21, 2022 | Issued |
Array
(
[id] => 18286805
[patent_doc_number] => 20230102277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DETECTION OF SYMMETRICAL DIMETHYLARGININE
[patent_app_type] => utility
[patent_app_number] => 17/877410
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17877410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/877410 | DETECTION OF SYMMETRICAL DIMETHYLARGININE | Jul 28, 2022 | Pending |